Trafermin (genetical recombination)

DRUG2 trials

Sponsors

Kaken Pharmaceutical

Conditions

Alveolar Bone LossPeriodontal Attachment LossPeriodontitis

Phase 2

A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan

CompletedNCT00199290

Kaken PharmaceuticalPeriodontitis

Start: 2005-08-31End: 2007-12-31Updated: 2008-02-05

Phase 3

Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)

CompletedNCT00734708

Kaken PharmaceuticalAlveolar Bone Loss, Periodontal Attachment Loss, Periodontitis

Start: 2008-08-31Updated: 2012-06-15